Paris - Delayed Quote EUR

Acticor Biotech SAS (ALACT.PA)

Compare
0.2500 0.0000 (0.00%)
At close: December 9 at 3:36:28 PM GMT+1
Currency in EUR All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
17,551.0000
17,551.0000
15,102.0000
11,831.0000
7,562.0000
Operating Income
-17,551.0000
-17,551.0000
-15,102.0000
-11,831.0000
-7,562.0000
Net Non Operating Interest Income Expense
-2,141.0000
-2,141.0000
-735.0000
-777.0000
-94.0000
Pretax Income
-18,640.0000
-18,640.0000
-15,878.0000
-12,608.0000
-7,651.0000
Net Income Common Stockholders
-18,640.0000
-18,640.0000
-15,878.0000
-12,608.0000
-7,651.0000
Diluted NI Available to Com Stockholders
-18,640.0000
-18,640.0000
-15,878.0000
-12,608.0000
-7,651.0000
Basic EPS
-1.54
-1.54
-1.51
-1.62
-0.73
Diluted EPS
-1.54
-1.54
-1.51
-1.62
-0.73
Basic Average Shares
12,068.4760
12,068.4760
10,545.7760
7,780.2920
10,545.7760
Diluted Average Shares
12,068.4760
12,068.4760
10,545.7760
7,780.2920
10,545.7760
Total Operating Income as Reported
-17,565.0000
-17,565.0000
-15,121.0000
-11,889.0000
-7,576.0000
Rent Expense Supplemental
570.0000
570.0000
108.0000
64.0000
121.0000
Total Expenses
17,551.0000
17,551.0000
15,102.0000
11,831.0000
7,562.0000
Net Income from Continuing & Discontinued Operation
-18,640.0000
-18,640.0000
-15,878.0000
-12,608.0000
-7,651.0000
Normalized Income
-19,695.0000
-19,695.0000
-15,878.0000
-12,608.0000
-7,651.0000
Interest Income
--
--
--
2.0000
--
Interest Expense
1,809.0000
1,809.0000
595.0000
721.0000
--
Net Interest Income
-2,141.0000
-2,141.0000
-735.0000
-777.0000
-94.0000
EBIT
-16,831.0000
-16,831.0000
-15,283.0000
-11,887.0000
-7,651.0000
EBITDA
-16,103.0000
-16,103.0000
-15,197.0000
-11,787.0000
-7,542.0000
Reconciled Depreciation
728.0000
728.0000
86.0000
96.0000
99.0000
Net Income from Continuing Operation Net Minority Interest
-18,640.0000
-18,640.0000
-15,878.0000
-12,608.0000
-7,651.0000
Total Unusual Items Excluding Goodwill
1,055.0000
1,055.0000
--
--
--
Total Unusual Items
1,055.0000
1,055.0000
--
--
--
Normalized EBITDA
-17,158.0000
-17,158.0000
-15,197.0000
-11,787.0000
-7,542.0000
12/31/2020 - 11/1/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ALTAO.PA ATON
0.0098
+1.03%
 
AELIS.PA Aelis Farma SA
2.0000
0.00%
 
ABNX.PA ABIONYX Pharma SA
1.2060
-0.82%
 
ALDVI.PA Advicenne S.A.
1.9900
0.00%
 
ALBPS.PA Biophytis S.A.
0.3720
+8.45%
 
ALVET.PA TheraVet SA
0.1070
-1.38%
 
ALINT.PA IntegraGen SA
0.5300
+2.91%
 
ALMDP.PA Medesis Pharma S.A.
0.3200
+1.59%
 
ALPAT.PA Plant Advanced Technologies SA
11.70
0.00%
 
ALCLS.PA Cellectis S.A.
1.4600
-1.35%